The C3 Epithelial Production Analysis and Innovation Core (EPAIC) is supported by a Research Development Program Grant from the Cystic Fibrosis Foundation. The C3EPAIC provides investigators with primary well differentiated human bronchial epithelial (HBE) or human nasal epithelial (HNE) cultures grown at an air-liquid interface (ALI). All cultures are from de-identified donors. The Core has a library of frozen HBE and HNE progenitor cells from CF donors with various CF genotypes and from non-CF donors.
How to Obtain Cultures
Investigators who wish to use HBE cultures for their experiments may submit a brief description of their project to the ECC Co-I, Mark Peeples. The request will be reviewed for feasibility and scientific merit.
|
Once your project is approved, request HBE and HNE cultures by contacting Phylip Chen:
[email protected] |
Donor characteristics are available and may include:
- Age
- Sex
- CF transmembrane conductance regulator (CFTR) genotype
- Microbiology report
- Body mass index (BMI)
- Smoking history
- Pancreatic treatment
- CF-related diabetes (CFRD)
- CFTR modulators, corrector, and/or potentiator treatments [Kalydeco (ivacaftor); Orkambi (ivacaftor/lumacaftor); Symdeko (ivacaftor/tezacaftor); Trikafta (ivacaftor/tezacaftor/elexacaftor)]
Certified non-heterozygotic control cultures are available to CF investigators, from nine donors who do not carry any of the 99 most common disabling mutations in either of their CFTR genes.
Consulting
The C3EPAIC provides advice on experimental design.
Your Role
The C3EPAIC establishes these cells on collagen-coated Transwells and feeds them for a week as they form tight junctions. Once the investigator is trained, they are provided with the cultures and enough freshly prepared medium to fully differentiate and maintain the cells during the experiment. If possible, we ask investigator to replace the Transwells used for their cultures to help defray the costs.
Analysis of Cultures
The C3EPAIC offers collaborative expertise in:
- RNA isolation for RNAseq and PCR arrays
- Mucus and mucin production (histology and immunofluorescence)
- Quantification of apically and basally released cytokines and chemokines
- Post-experiment culture staining to quantify the differentiated cell types in the HBE and HNE cultures (including ciliated and goblet cells)
- Electrophysiology to determine CFTR function
- Immunoblotting to determine CFTR maturity
- Mucociliary function (airway surface liquid and ciliary beat frequency)
How are HBE cultures established?
Bronchial progenitor cells are extracted from the airways of explanted CF lungs or non-CF donor lungs by protease digestion. Nasal progenitor cells are isolated from nasal brushings of live donors. Progenitor cells are enriched and amplified by growth on collagen-coated plastic for a week in the presence of ROCK inhibitor. The expanded progenitor cells are stored frozen. Upon thawing, cells are plated on collagen-coated Transwell filters with medium in the upper and lower chambers, and grown in the presence of ROCK inhibitor for one week to allow tight junctions to form. The apical medium is removed, and differentiation medium is placed in the basal chamber. Over the course of the next three weeks, these cultures become pseudostratified, and differentiate into cells with beating cilia, goblet cells that produce mucus, and other cell types. The cilia move the mucus around the well usually in a hurricane-like motion from the central point of the well.
Acknowledging C3EPAIC
Publications resulting from studies supported by C3ECC should include the following acknowledgement:
The Cure Cystic Fibrosis Columbus (C3) Epithelial Production, Analysis, and Innovation Core (EPAIC) at Nationwide Children’s Hospital (NCH) and The Ohio State University (OSU) provided primary human bronchial (or nasal) epithelial cultures, advice, and tools for this work, with the help of the NCH Biopathology Center Core and Data Collaboration Team. C3 is supported by a Cystic Fibrosis Foundation Research Development Program Grant (MCCOY17R2), the NCH Division of Pediatric Pulmonary Medicine (MCCOY19Ro), and the OSU Center for Clinical and Translational Science (UL1TR002733). Source tissues were provided by the Comprehensive Transplant Center Human Tissue Biorepository of The OSU Wexner Medical Center. (If nasal: by nasal brushings from volunteers.)